Hamps Bio Ltd (HAMPS) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Hamps Bio Ltd on NSE and BSE, with an AI summary of each filing.
Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Standalone And Consolidated ....
Intimation · 06 Nov 2026, 5:30 am
Hamps Bio Schedules Board Meeting on 6th Nov'26 for Half-Yearly Results Hamps Bio Limited has informed BSE that a meeting of its Board of Directors is scheduled for Friday, 6th Nov'26, at its registered office. The board will primarily consider and approve the unaudited standalone and consolidated financial results of the company for the half year ended 30th Sep'26, alongside taking on record the Limited Review Report.
The voting results along with the Scrutinizer report for 19th AGM is attached herewith.
Annual General Meeting · 11 Sept 2026, 5:07 pm
Board Meeting Outcome for Board Meeting held on 9th September, 2026.
Others (Uncategorized) · 09 Sept 2026, 11:44 pm
Hamps Bio Approves Remuneration Hikes for Key Executives and Board Members Hamps Bio Limited’s Board of Directors, at its meeting held on 9th Sep'26, approved key remuneration proposals based on recommendations from the Nomination and Remuneration Committee. The Board sanctioned an increase in remuneration for Chairman and Managing Director Herrik Mountbaton Shah, Whole-Time Director Shrenikkumar Mountkumar Shah, and Chief Financial Officer Mitali Shrenikkumar Shah. Additionally, the Board approved the remuneration payable to Director Pallavi Herrik Shah.
The proceedings of 19th AGM is attached herewith.
Annual General Meeting · 09 Sept 2026, 10:50 pm
We have attached herewith the annual report for the financial year 2025-26.
Others (Uncategorized) · 18 Aug 2026, 1:15 am
We have attached herewith the Annual General Meeting notice for the year 2025-26.
Annual General Meeting · 18 Aug 2026, 12:53 am
Outcome of Board Meeting.
Others (Uncategorized) · 13 Aug 2026, 12:17 am
Hamps Bio Board Approves Reports, AGM Date, and Office Relocation The Hamps Bio Ltd. board, in its meeting on 12 Aug'26, approved the Board Report and draft Annual Report for the year ended 31 Mar'26. The 19th Annual General Meeting (AGM) is scheduled for 09 Sep'26. Key proposals for shareholder approval include the re-appointment of Director Mrs. Pallavi Herrik Shah and shifting the registered office from Ankleshwar to Surat, within Gujarat. The board also appointed a scrutinizer for the AGM voting process.
Intimation under Regulation 30(5) of the SEBI LODR
Others (Uncategorized) · 06 Jul 2026, 11:54 pm
Hamps Bio Discloses Key Managerial Personnel for Regulatory Filings Hamps Bio Ltd. has disclosed its list of Key Managerial Personnel (KMP) authorized to determine the materiality of events and make necessary disclosures to stock exchanges, effective 06 Jul'26. The authorized KMPs include Mr. Herrik Mountbaton Shah (Managing Director), Mr. Shrenikkumar Mountkumar Shah (Whole-time Director), Mrs. Mitali Shrenikkumar Shah (Chief Financial Officer), and Mr. Ravi Baheti (Company Secretary & Compliance Officer). This action complies with SEBI's Regulation 30(5) for listing obligations.
Appointment of Company Secretary and Compliance officer is attached herewith.
Change in Management · 06 Jul 2026, 11:50 pm
Hamps Bio Appoints New Company Secretary and Compliance Officer Hamps Bio Ltd.’s Board approved the resignation of Company Secretary & Compliance Officer, Ms. Komal Jain, effective from 30 Jun'26. Mr. Ravi Baheti has been appointed as her replacement with effect from 06 Jul'26. Mr. Baheti is an Associate Member of the ICSI and has over nine years of experience in corporate governance, compliance management, and secretarial functions. The Board also authorized Key Managerial Personnel (KMPs) to determine the materiality of events for future stock exchange disclosures.
Resignation of company secretary is attached herewith.
Change in Management · 06 Jul 2026, 11:45 pm
Hamps Bio Appoints New Company Secretary and Compliance Officer Hamps Bio Ltd.’s board approved key management changes on 06 Jul'26. The company accepted the resignation of Ms. Komal Jain as Company Secretary & Compliance Officer, effective 30 Jun'26. Mr. Ravi Baheti, an ICSI member with over nine years of experience in corporate governance and compliance, was appointed as her replacement, effective 06 Jul'26. The board also authorized key management personnel to determine the materiality of events for stock exchange disclosures.
Outcome of Board Meeting dated 06.07.2026 is attached herewith.
Others (Uncategorized) · 06 Jul 2026, 11:41 pm
Hamps Bio Appoints New Company Secretary and Compliance Officer Hamps Bio's Board approved the appointment of Mr. Ravi Baheti as the new Company Secretary and Compliance Officer, effective 06 Jul'26. This follows the acceptance of Ms. Komal Jain's resignation, which was effective from 30 Jun'26 due to personal reasons. Mr. Baheti is an ICSI member with over nine years of experience in corporate governance and secretarial work. The Board also authorized Key Managerial Personnel (KMP) to determine the materiality of events for stock exchange disclosures.
Pursuant to regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that Ms. Komal Jain Company Secretary and Compliance Officer of the company has tendered her resignation ....
Change in Management · 30 Jun 2026, 11:31 pm
Hamps Bio Company Secretary & Compliance Officer Resigns Hamps Bio Ltd. announced the resignation of Ms. Komal Jain, the Company Secretary & Compliance Officer. She tendered her resignation on 19th Jun'26, citing personal reasons, which the company accepted. Her last day of service will be 30th Jun'26. This key management personnel change is a notable event for corporate governance and regulatory compliance oversight.
Re-appointment of Internal Auditor of Hamps Bio Limited
Change in Management · 30 May 2026, 2:07 am
Hamps Bio Appoints New Internal Auditor for FY27 Hamps Bio Ltd. has appointed M/s Naviwala & Associates, a Surat-based chartered accountancy firm, as its Internal Auditor for the financial year 2026-27. The appointment is effective from 29 May'26, as approved by the Board of Directors in their meeting on the same day. This corporate governance update fulfills regulatory disclosure requirements under SEBI's Listing Regulations. Naviwala & Associates, founded in Jul'20, will assume the internal audit responsibilities for the upcoming fiscal year.
The Financial results for the year ended 31-03-2026 are attached herewith.
Financial Result · 30 May 2026, 2:02 am
Hamps Bio FY26 Results: Widening Losses Despite Revenue Growth Hamps Bio reported consolidated results for the year ended 31st Mar'26. Revenue from operations grew 27.1% YoY to ₹847.46 lakhs, while total income rose to ₹880.67 lakhs from ₹681.98 lakhs. However, the company posted a net loss after tax of ₹73.87 lakhs, a significant decline from a profit of ₹29.77 lakhs in FY25. The loss was driven by a 48.1% surge in total expenses to ₹950.65 lakhs. Consequently, basic EPS for FY26 stood at negative ₹0.85, compared to positive ₹0.68 in the previous year.
Standalone and consolidated Audited Financial Results for the Half Year and Year to date ended March 31, 2026, along with Auditor''s Report thereon is attached herewith.
Outcome · 30 May 2026, 1:47 am
Hamps Bio Ltd FY26 Results: Widened Losses Amidst Higher Revenue and Expenses Hamps Bio reported audited consolidated results for FY26 ending 31st Mar'26. Revenue from operations grew 27.0% YoY to Rs 847.46 lakhs, while total expenses increased 48.1% to Rs 950.65 lakhs. This resulted in a net loss after tax of Rs 73.87 lakhs, a significant decline from the Rs 29.77 lakh profit in FY25. The loss was driven by higher employee benefits and other expenses. Basic EPS stood at Rs (0.85) vs Rs 0.68 in the prior year. The company also appointed a new internal auditor.
Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Hamps Bio Ltd has informed BSE that ....
Intimation · 29 May 2026, 5:30 am
Hamps Bio Board Meeting on May 29, 2026 to Approve Financial Results Hamps Bio Ltd. (BSE: 544312) has scheduled a Board of Directors meeting on May 29, 2026. Key agenda items include the consideration and approval of audited standalone and consolidated financial results for the half-year and full-year ended Mar 31, 2026. The board will also consider the appointment of Naviwala & Associates as the internal auditor for the financial year 2026-2027.
Update on Acquistion of 100% equity shares of HSDL Innovative Private Limited. This is to inform you that the Company has completed acquisition of 100% paid up equity share capital of HSDL ....
Others (Uncategorized) · 25 Mar 2026, 10:12 pm
Hamps Bio Completes Acquisition of HSDL Innovative, Creating a Wholly Owned Subsidiary Hamps Bio Ltd. has completed the acquisition of 100% of HSDL Innovative Private Limited for a cash consideration of INR 2.04 crore. Following the transaction, HSDL Innovative has officially become a Wholly Owned Subsidiary (WOS) of Hamps Bio, effective 25th Mar'26. This move concludes the acquisition process initially announced on 14th Feb'26.
Considered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.
Others (Uncategorized) · 14 Feb 2026, 11:05 pm
Hamps Bio to Acquire HSDL Innovative for INR 2.04 Crore in Cash Hamps Bio's board approved the acquisition of 100% of HSDL Innovative Private Limited on 14 Feb'26 for a cash consideration of INR 2.04 Cr. The target, a related party, is in the freeze-drying food business and had a turnover of INR 1.87 Cr in FY25. The acquisition aims to consolidate the freeze-drying business under the Hamps Bio umbrella. Upon completion within 60 days, HSDL Innovative will become a wholly-owned subsidiary of Hamps Bio.
Considered and approved the acquisition of 100% of paid-up equity share capital of HSDL Innovative Private Limited.
Others (Uncategorized) · 14 Feb 2026, 10:57 pm
Hamps Bio to Acquire HSDL Innovative Private Limited in All-Cash Deal Hamps Bio's board on Feb 14, '26, approved the acquisition of 100% equity in HSDL Innovative Private Limited for a cash consideration of INR 2.04 crore. The target company, operating in the freeze-drying food sector, is a related party of Hamps Bio. For FY25, HSDL Innovative reported a turnover of INR 1.87 crore. The acquisition aims to consolidate the freeze-drying food business under Hamps Bio. Post-acquisition, HSDL will become a wholly-owned subsidiary. The transaction is expected to be completed within 60 days.
We have attached herewith the Scrutinizer''s Report. Kindly take the same on your record.
Extra Ordinary General Meeting · 25 Nov 2025, 11:39 pm
Enclosed herewith is the outcome of EGM of the company held on Monday 24th November 2025 at the corporate office of the company.
Extra Ordinary General Meeting · 25 Nov 2025, 12:05 am
Unaudited Financial Results for the Half Year Ended 30.09.2025 is attached herewith.
Financial Result · 15 Nov 2025, 12:56 am
The Unaudited Financial Results for the half year ended on 30.09.2025 is attached herewith for your reference.
Outcome · 15 Nov 2025, 12:44 am
Intimation for re-scheduling the date of the Board Meeting is attached herewith.
Intimation · 14 Nov 2025, 5:30 am
Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Unaudited Financial Results for the ....
Intimation · 13 Nov 2025, 5:30 am